10-Q: Planet 13 Reports Q2 Loss Amid Revenue Decline, Florida Expansion

Planet 13 Holdings Inc. reported a significant net loss for the second quarter of 2025, driven by decreased revenue and increased operating expenses, despite strategic expansion in Florida and a legal settlement recovery.

Summary

• Net loss for the three months ended June 30, 2025, was $13.3 million, a 64.8% increase from $8.1 million in the prior year period.
• Net revenue for the three months ended June 30, 2025, decreased by 13.6% to $26.9 million, primarily due to price compression in all markets and increased competition.
• Gross profit margin declined to 43.4% in Q2 2025 from 50.9% in Q2 2024, a result of pricing pressure in retail and wholesale channels.
• For the six months ended June 30, 2025, net revenue increased by 1.7% to $54.9 million, largely attributable to the VidaCann acquisition.
• Cash flows used in operating activities were $6.4 million for the six months ended June 30, 2025, a significant negative shift from cash provided of $3.8 million in the prior year.
• The company recovered $5.5 million in funds and real estate valued at $5.0 million from the El Capitan legal settlement, contributing $5.3 million to other income for the six-month period.
• Working capital stood at $21.2 million as of June 30, 2025.
• The 2023 Equity Incentive Plan was amended to increase the total shares authorized for grants from 22 million to 32 million.

Sentiment

Score: 3

Explanation: The company reported a significant increase in net loss and a decrease in revenue and gross margin for the quarter, indicating deteriorating operational performance. While there was a substantial legal settlement recovery, it masks underlying operational challenges. Negative cash flow from operations and a declining cash balance are concerning, despite management's assertion of adequate liquidity for the next 12 months. The competitive market and ongoing federal illegality of cannabis continue to pose significant headwinds.

Positives

• Successful recovery of $5.5 million in funds and real estate valued at $5.0 million from the El Capitan legal settlement, significantly boosting other income.
• VidaCann cultivation operations showed improved yields and lower operational costs due to implemented upgrades and efficiency measures.
• Strategic expansion in Florida continues with 32 medical dispensaries now operational and four additional leases secured for future locations.
• Renewal of the $9.75 million revolving line of credit, extending its term to June 30, 2026, maintaining financial flexibility.
• Working capital remains positive at $21.2 million, and management believes it has adequate liquidity for the next 12 months, supported by planned property sales.

Negatives

• Net loss significantly increased by 64.8% to $13.3 million for the three months ended June 30, 2025, compared to $8.1 million in the prior year.
• Net revenue decreased by 13.6% to $26.9 million for the three months ended June 30, 2025, driven by price compression and increased competition across all markets.
• Gross profit margin declined to 43.4% for the three months ended June 30, 2025, from 50.9% in the prior year, primarily due to pricing pressure.
• Cash flows used in operating activities were $6.4 million for the six months ended June 30, 2025, a substantial negative shift from cash provided by operating activities of $3.8 million in the prior year.
• General and administrative expenses increased by 24.0% for the six months ended June 30, 2025, partly due to the VidaCann acquisition and increased share-based compensation.
• Interest expense shifted from a net income of $84,580 in Q2 2024 to a net expense of $377,290 in Q2 2025, primarily due to the revolving line of credit and long-term debt.
• The company expects to incur a $502,000 loss on the sale of the Santa Barbara property in Q3 2025.

Risks

• Actual financial position and results of operations may differ from management's expectations.
• Lack of business diversification and increasing competition in the cannabis industry.
• Public opinion and perception of the cannabis industry could negatively impact business.
• Significant costs and obligations associated with operations and expansion.
• Current reliance on limited jurisdictions (Nevada, California, Florida, Illinois) exposes the company to regional economic downturns.
• Access to capital is uncertain, and there is no assurance of continued access to significant equity financing or favorable terms.
• Risks inherent in an agricultural business, including energy costs and reliance on suppliers.
• U.S. federal law classifies marijuana as a Schedule I drug, making its use illegal federally, which could lead to fines, restrictions, loss of permits, or asset forfeiture.
• Heightened scrutiny by Canadian regulatory authorities and risks related to capital raising due to such scrutiny.
• Significant tax liabilities due to Section 280E of the Internal Revenue Code, which prohibits deductions for businesses trafficking in controlled substances, leading to taxes on gross profit.
• Difficulty accessing the U.S. banking system and traditional financing sources due to federal illegality of cannabis.
• Price volatility of common stock and potential future sales by shareholders.
• Litigation risks, including intellectual property disputes, product recalls, and general claims.
• Inability to attract and retain key personnel.
• Risks related to integration of acquired businesses.
• Impact of the illicit market for cannabis and manufacturers/retailers of intoxicating hemp products.

Future Outlook

The company plans to expand the sale of its exclusive brands, starting with the HaHa line of infused gummy products, to third-party dispensaries in the Illinois market through its wholesale distribution network in the second half of 2025. Management believes it has adequate liquidity from cash on hand and expected proceeds from property sales ($6 million to $7 million in H2 2025) to fund planned capital expenditures, Florida expansion, and operations for the next 12 months. However, it acknowledges a history of operating losses and the uncertainty of obtaining additional financing on favorable terms.

Management Comments

• "We believe that a decline in tourism, combined with an overall reduction in the disposable income of our customers during the six months ended June 30, 2025, had a negative impact on the number of tourists and local customers visiting the Planet 13 Las Vegas Superstore and our other retail locations."
• "The Company saw a reduction in the number of customers at the Planet 13 Las Vegas Superstore compared to the prior year, and decreases in revenue from both retail operations and wholesale operations in California and Nevada."
• "The costs of internal cultivation in the three months ended June 30, 2025 were consistent with the prior period as the Company continues to focus on producing strains with highest yields and THC content across all of our cultivation facilities."
• "The cost of internal cultivation at our VidaCann operations improved during the three months ended June 30, 2025 as upgrades and efficiency measures implemented have had a positive impact on yields and lower operational costs."
• "Management believes it will be able to raise equity capital as required in the long term, but recognizes the risks attached thereto. There can be no assurance that it will be able to obtain adequate financing in the future or that the terms of such financing may be favorable."
• "Should financing not be available, the Company has adequate liquidity in the form of cash on hand to fund all of its planned capital expenditures and expansion plans as well as to continue to fund its operation over the next 12 months, including the planned build-out of its operations in Florida."

Industry Context

The cannabis industry remains highly competitive, with increased pressure from larger, better-financed competitors and new market entrants. Price compression is a significant factor impacting retail and wholesale revenues across all markets where Planet 13 operates. The illicit market and intoxicating hemp products continue to pose a direct financial challenge. The company's strategy of focusing on customer experience, product innovation, and cost control is a direct response to these competitive pressures. The ongoing federal illegality of cannabis in the U.S. continues to create significant operational and financial burdens, particularly regarding tax liabilities under Section 280E and access to traditional banking services, which is a pervasive issue for the entire regulated cannabis sector.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not presently a party to any legal proceedings that, in management's opinion, would individually or taken together have a material adverse effect on its business, operating results, financial condition, or cash flows.
• Litigation can still have an adverse impact due to defense and settlement costs, diversion of management resources, negative publicity, and reputational harm.

Related Party Transactions

• Long-term lease agreement with Loop's Nursery (primarily owned by David Loop, a board member) for the primary cultivation facility in Florida. Payments for rent and associated costs for six months ended June 30, 2025, totaled $1,802,824.
• Acquired related party notes payable to David Loop and Mark Ascik (VidaCann former managers) in the amounts of $750,000 each as part of the VidaCann acquisition. Interest payments for six months ended June 30, 2025, totaled $56,096 combined.
• Entered into a 30-month lease agreement with PRMN Investments Ltd (primarily owned by Robert Groesbeck, Co-CEO) for a Florida apartment unit used for executive travel. Payments for rent and associated costs for six months ended June 30, 2025, totaled $22,288.

Stakeholder Impact

• Shareholders: Increased net losses and declining gross margins could negatively impact shareholder value. The increase in authorized shares for the equity incentive plan could lead to further dilution. The legal settlement recovery provides a temporary positive, but operational challenges persist.
• Employees: The company employs approximately 785 full-time and 71 part-time employees, and ongoing cost-cutting initiatives could impact job security or compensation.
• Customers: Price compression and competitive conditions suggest customers may benefit from lower prices or enhanced loyalty programs, but a decline in customer numbers at the Las Vegas Superstore indicates potential dissatisfaction or market saturation.
• Creditors: The company's increased net loss and negative operating cash flow could raise concerns, though the renewal of the revolving line of credit and planned property sales aim to maintain liquidity.
• Suppliers: Reliance on suppliers and risks related to energy costs could impact the supply chain.

Next Steps

• Expand the sale of exclusive brands (e.g., HaHa gummies) to third-party dispensaries in the Illinois market in the second half of 2025.
• Complete tenant improvements and regulatory inspections for four additional dispensing locations in Florida.
• Sell two properties (Santa Barbara, Summerfield FL) in the second half of 2025, with expected net proceeds of $6 million to $7 million, to fund operations and Florida expansion.
• Continue to focus on customer experience, product innovation, production efficiencies, marketing and branding, and ongoing cost control and reductions.

Key Dates

Recommendation

The company faces significant operational headwinds, including declining revenues and gross margins in its core markets, coupled with increasing net losses and negative operating cash flow. While the VidaCann acquisition contributed to overall revenue growth for the six-month period and a substantial legal settlement recovery provided a one-time boost to other income, these positives are overshadowed by the deteriorating profitability and cash burn. Management's confidence in liquidity for the next 12 months relies on planned property sales and a renewed credit line, but the long-term financing outlook remains uncertain given a history of operating losses and the challenging regulatory environment for cannabis. The stock is a 'hold' as the company navigates these challenges, with potential for improvement if Florida expansion proves highly successful and cost-cutting measures yield significant results, but substantial risks remain.

Keywords

Cannabis, Marijuana, Dispensary, Cultivation, Nevada, California, Florida, Illinois, VidaCann, SEC Filing, 10-Q, Financial Results, Cannabis Industry, Multi-state operator, PLNH, PLTH, Superstore, Cannabis Retail, Cannabis Wholesale, Equity Incentive Plan, Capital Resources, Operating Loss, Gross Margin, El Capitan Settlement